TP53 and telomere syndrome: Commonly identified alterations in gene expression and pathway regulation in human STS, including altered TP53 signaling, activation of Wnt signaling, and evidence of epigenetic reprogramming were identified in Oncopig leiomyosarcomas and STS cell lines.